Navigation Links
Highmark's Hospital Pay-for-Performance Program Demonstrates Impressive Results
Date:10/11/2007

Model Program Saves Money and Improves Quality of Health Care

PITTSBURGH, Oct. 11 /PRNewswire/ -- During the past year, Highmark has worked with select hospitals in Western Pennsylvania as part of its pay-for- performance program called QualityBLUE to significantly reduce central line- associated bloodstream infections.

Central lines are used to monitor patient status and deliver medication and nutrition to critically ill patients through vessels that lead directly to the heart. Bacteria introduced through these lines can lead to life- threatening infections. The national average, is five infections per 1,000 line days for intensive care unit patients. The average hospital-wide rate for hospitals in the QualityBLUE program was only 1.5 per 1,000 line days.

While there were 214 such infections at QualityBLUE hospitals in the past year, had they occurred at the national average rate, there would have been a potential of 1,115 infections. At an estimated cost of $36,000 per case, that represents a potential savings to the health care system of more than $32 million.

"There are numerous areas which participating hospitals and Highmark focus, but this specific measure really shows the progress the program is making," said Michael Madden, M.D., medical director of medical performance management programs for Highmark. "These hospitals are safer for patients, and there is a significant cost savings. The QualityBLUE program is really making a difference when it comes to quality care for our members."

The Highmark QualityBLUE hospital pay-for-performance program began in fiscal year 2002 with six hospitals. Today, 29 hospitals participate in the program in Western Pennsylvania, and the program was recently expanded and now includes one hospital in Central Pennsylvania, with further expansion projected. Since the inception of the program, the number of hospital QualityBLUE participants has grown to encompass more than 60 percent of Highmark's inpatient/outpatient hospital claims in the Western region.

QualityBLUE also focuses on the prevention, reduction and/or elimination of Methicillin Resistant Staphylococcus Aureus (MRSA). Hospital participants in QualityBLUE screen patients when they are admitted to high-risk areas, such as the intensive care unit. During the past year, 8.4 percent of patients were identified as carriers of MRSA. When a patient is found to be a carrier of MRSA or infected with it, hospitals implement precautions to prevent the spread of the bacteria to others, reducing hospital-acquired infections. Some of those precautions include isolating the patient, using only dedicated equipment, strict adherence to appropriate hand hygiene and wearing protective clothing such as gowns and gloves.

"By implementing these specific measures to deal with MRSA, participating hospitals have made it safer for patients and reduced the spread of this difficult-to-treat infection," said Madden.

"We applaud Highmark in their efforts to provide positive incentives to help improve the quality of healthcare," said John Jernigan, M.D., Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention.

"Their results suggest that patients can benefit when insurance carriers work with hospitals to improve care through a strategy of positive reinforcement."

Highmark Inc.

As one of the leading health insurers in Pennsylvania, Highmark Inc.'s mission is to provide access to affordable, quality health care enabling individuals to live longer, healthier lives. Based in Pittsburgh, Highmark serves 4.6 million people through the company's health care benefits business. Highmark contributes millions of dollars to help keep quality health care programs affordable and to support community-based programs that work to improve people's health. Highmark exerts an enormous economic impact throughout Pennsylvania. A recent study states that Highmark's positive impact exceeded $2.5 billion. The company provides the resources to give its members a greater hand in their health.

Highmark Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield Plans. For more information, visit http://www.highmark.com.


'/>"/>
SOURCE Highmark Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. Apollo Hospitals to consider listing on US Bourses in 2003
3. The World Bank funds private Hospital in India
4. Ambulance queue before hospitals with emergency patients
5. Greater volume hospitals better for stroke
6. Spurt in hospital admissions following football shoot-outs
7. Machines take over the battle against hospital bugs
8. New way to control hospital infection
9. Link Between Hyperglycemia & Hospital Mortality
10. Reducing The Rate Of Hospital Acquired Infections
11. Home-based Treatment For Eczema More Effective Compared To Hospital Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, ... announce an upgrade to the company's Yelp listing. Bay Area residents struggling from ... diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular ...
(Date:2/26/2017)... MICHIGAN (PRWEB) , ... February 25, 2017 , ... The ... Kim Jong-un, heightened awareness and concern over nerve agents and the deadly use of ... the human nervous system and how even small doses can be lethal. , Jay ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... YORK , Feb. 23, 2017  Genesis Healthcare ... Company. The announcement was made by Bill Monast ... David Hartley and Nathan Feltman , executives ... Genesis Healthcare Services, LLC. This acquisition ... largest provider of technology enabled durable medical equipment (DME) ...
Breaking Medicine Technology: